COVID-19 Impact on Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: CD93B507DC28EN
QYResearch

Abstracts

This report focuses on the global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Cancer Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott
• Merck
• Novartis
• Amgen
• Celgene
• Bayer
• Roche
• Astellas
• Astrazeneca
• Johnson & Johnson
• Agilent
• Takeda

Market segment by Type, the product can be split into

• Monoclonal Antibodies
• Personalized Cancer Vaccines
• Other

Market segment by Application, split into

• Breast Cancer
• Lung Cancer
• Chronic Myeloid Leukaemia
• Bowel Cancer
• Other Cancer

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players.
• To present the Personalized Cancer Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Personalized Cancer Medicine are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
1.4 Market Analysis by Type
  1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monoclonal Antibodies
  1.4.3 Personalized Cancer Vaccines
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026
  1.5.2 Breast Cancer
  1.5.3 Lung Cancer
  1.5.4 Chronic Myeloid Leukaemia
  1.5.5 Bowel Cancer
  1.5.6 Other Cancer
1.6 Coronavirus Disease 2019 (Covid-19): Personalized Cancer Medicine Industry Impact
  1.6.1 How the Covid-19 is Affecting the Personalized Cancer Medicine Industry
    1.6.1.1 Personalized Cancer Medicine Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Personalized Cancer Medicine Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Personalized Cancer Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Personalized Cancer Medicine Market Perspective (2015-2026)
2.2 Personalized Cancer Medicine Growth Trends by Regions
  2.2.1 Personalized Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Personalized Cancer Medicine Historic Market Share by Regions (2015-2020)
  2.2.3 Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Personalized Cancer Medicine Market Growth Strategy
  2.3.6 Primary Interviews with Key Personalized Cancer Medicine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Personalized Cancer Medicine Players by Market Size
  3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2015-2020)
  3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Personalized Cancer Medicine Market Concentration Ratio
  3.2.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2019
3.3 Personalized Cancer Medicine Key Players Head office and Area Served
3.4 Key Players Personalized Cancer Medicine Product Solution and Service
3.5 Date of Enter into Personalized Cancer Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2015-2020)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2021-2026)

5 PERSONALIZED CANCER MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Personalized Cancer Medicine Market Size by Application (2015-2020)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Personalized Cancer Medicine Market Size (2015-2020)
6.2 Personalized Cancer Medicine Key Players in North America (2019-2020)
6.3 North America Personalized Cancer Medicine Market Size by Type (2015-2020)
6.4 North America Personalized Cancer Medicine Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Personalized Cancer Medicine Market Size (2015-2020)
7.2 Personalized Cancer Medicine Key Players in Europe (2019-2020)
7.3 Europe Personalized Cancer Medicine Market Size by Type (2015-2020)
7.4 Europe Personalized Cancer Medicine Market Size by Application (2015-2020)

8 CHINA

8.1 China Personalized Cancer Medicine Market Size (2015-2020)
8.2 Personalized Cancer Medicine Key Players in China (2019-2020)
8.3 China Personalized Cancer Medicine Market Size by Type (2015-2020)
8.4 China Personalized Cancer Medicine Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Personalized Cancer Medicine Market Size (2015-2020)
9.2 Personalized Cancer Medicine Key Players in Japan (2019-2020)
9.3 Japan Personalized Cancer Medicine Market Size by Type (2015-2020)
9.4 Japan Personalized Cancer Medicine Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Personalized Cancer Medicine Market Size (2015-2020)
10.2 Personalized Cancer Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020)

11 INDIA

11.1 India Personalized Cancer Medicine Market Size (2015-2020)
11.2 Personalized Cancer Medicine Key Players in India (2019-2020)
11.3 India Personalized Cancer Medicine Market Size by Type (2015-2020)
11.4 India Personalized Cancer Medicine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Personalized Cancer Medicine Market Size (2015-2020)
12.2 Personalized Cancer Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020)
12.4 Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Personalized Cancer Medicine Introduction
  13.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Merck
  13.2.1 Merck Company Details
  13.2.2 Merck Business Overview and Its Total Revenue
  13.2.3 Merck Personalized Cancer Medicine Introduction
  13.2.4 Merck Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.2.5 Merck Recent Development
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Personalized Cancer Medicine Introduction
  13.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.3.5 Novartis Recent Development
13.4 Amgen
  13.4.1 Amgen Company Details
  13.4.2 Amgen Business Overview and Its Total Revenue
  13.4.3 Amgen Personalized Cancer Medicine Introduction
  13.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.4.5 Amgen Recent Development
13.5 Celgene
  13.5.1 Celgene Company Details
  13.5.2 Celgene Business Overview and Its Total Revenue
  13.5.3 Celgene Personalized Cancer Medicine Introduction
  13.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.5.5 Celgene Recent Development
13.6 Bayer
  13.6.1 Bayer Company Details
  13.6.2 Bayer Business Overview and Its Total Revenue
  13.6.3 Bayer Personalized Cancer Medicine Introduction
  13.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.6.5 Bayer Recent Development
13.7 Roche
  13.7.1 Roche Company Details
  13.7.2 Roche Business Overview and Its Total Revenue
  13.7.3 Roche Personalized Cancer Medicine Introduction
  13.7.4 Roche Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.7.5 Roche Recent Development
13.8 Astellas
  13.8.1 Astellas Company Details
  13.8.2 Astellas Business Overview and Its Total Revenue
  13.8.3 Astellas Personalized Cancer Medicine Introduction
  13.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.8.5 Astellas Recent Development
13.9 Astrazeneca
  13.9.1 Astrazeneca Company Details
  13.9.2 Astrazeneca Business Overview and Its Total Revenue
  13.9.3 Astrazeneca Personalized Cancer Medicine Introduction
  13.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.9.5 Astrazeneca Recent Development
13.10 Johnson & Johnson
  13.10.1 Johnson & Johnson Company Details
  13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
  13.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020)
  13.10.5 Johnson & Johnson Recent Development
13.11 Agilent
  10.11.1 Agilent Company Details
  10.11.2 Agilent Business Overview and Its Total Revenue
  10.11.3 Agilent Personalized Cancer Medicine Introduction
  10.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2015-2020)
  10.11.5 Agilent Recent Development
13.12 Takeda
  10.12.1 Takeda Company Details
  10.12.2 Takeda Business Overview and Its Total Revenue
  10.12.3 Takeda Personalized Cancer Medicine Introduction
  10.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2015-2020)
  10.12.5 Takeda Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Personalized Cancer Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Personalized Cancer Medicine Revenue
Table 3. Ranking of Global Top Personalized Cancer Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Personalized Cancer Vaccines
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Personalized Cancer Medicine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Personalized Cancer Medicine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Personalized Cancer Medicine Players to Combat Covid-19 Impact
Table 13. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Personalized Cancer Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Personalized Cancer Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Personalized Cancer Medicine Market Share by Regions (2015-2020)
Table 17. Global Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Personalized Cancer Medicine Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Personalized Cancer Medicine Market Growth Strategy
Table 23. Main Points Interviewed from Key Personalized Cancer Medicine Players
Table 24. Global Personalized Cancer Medicine Revenue by Players (2015-2020) (Million US$)
Table 25. Global Personalized Cancer Medicine Market Share by Players (2015-2020)
Table 26. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2019)
Table 27. Global Personalized Cancer Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Personalized Cancer Medicine Product Solution and Service
Table 30. Date of Enter into Personalized Cancer Medicine Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 33. Global Personalized Cancer Medicine Market Size Share by Type (2015-2020)
Table 34. Global Personalized Cancer Medicine Revenue Market Share by Type (2021-2026)
Table 35. Global Personalized Cancer Medicine Market Size Share by Application (2015-2020)
Table 36. Global Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 37. Global Personalized Cancer Medicine Market Size Share by Application (2021-2026)
Table 38. North America Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 40. North America Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 41. North America Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 42. North America Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 43. North America Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 44. Europe Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 46. Europe Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 48. Europe Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 50. China Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 51. China Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 52. China Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 53. China Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 54. China Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 55. China Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 56. Japan Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 58. Japan Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 60. Japan Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 64. Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 66. Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 68. India Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 69. India Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 70. India Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 71. India Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 72. India Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 73. India Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Personalized Cancer Medicine Market Share (2019-2020)
Table 76. Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Personalized Cancer Medicine Market Share by Type (2015-2020)
Table 78. Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Personalized Cancer Medicine Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Amgen Company Details
Table 96. Amgen Business Overview
Table 97. Amgen Product
Table 98. Amgen Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 99. Amgen Recent Development
Table 100. Celgene Company Details
Table 101. Celgene Business Overview
Table 102. Celgene Product
Table 103. Celgene Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 104. Celgene Recent Development
Table 105. Bayer Company Details
Table 106. Bayer Business Overview
Table 107. Bayer Product
Table 108. Bayer Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 109. Bayer Recent Development
Table 110. Roche Company Details
Table 111. Roche Business Overview
Table 112. Roche Product
Table 113. Roche Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 114. Roche Recent Development
Table 115. Astellas Business Overview
Table 116. Astellas Product
Table 117. Astellas Company Details
Table 118. Astellas Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 119. Astellas Recent Development
Table 120. Astrazeneca Company Details
Table 121. Astrazeneca Business Overview
Table 122. Astrazeneca Product
Table 123. Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 124. Astrazeneca Recent Development
Table 125. Johnson & Johnson Company Details
Table 126. Johnson & Johnson Business Overview
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 129. Johnson & Johnson Recent Development
Table 130. Agilent Company Details
Table 131. Agilent Business Overview
Table 132. Agilent Product
Table 133. Agilent Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 134. Agilent Recent Development
Table 135. Takeda Company Details
Table 136. Takeda Business Overview
Table 137. Takeda Product
Table 138. Takeda Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$)
Table 139. Takeda Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Personalized Cancer Medicine Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Personalized Cancer Vaccines Features
Figure 4. Other Features
Figure 5. Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026
Figure 6. Breast Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Chronic Myeloid Leukaemia Case Studies
Figure 9. Bowel Cancer Case Studies
Figure 10. Other Cancer Case Studies
Figure 11. Personalized Cancer Medicine Report Years Considered
Figure 12. Global Personalized Cancer Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Personalized Cancer Medicine Market Share by Regions: 2020 VS 2026
Figure 14. Global Personalized Cancer Medicine Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Personalized Cancer Medicine Market Share by Players in 2019
Figure 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2019
Figure 19. North America Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 28. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 32. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 36. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 38. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 40. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 42. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 46. Agilent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 48. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed